Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
This study has suspended participant recruitment.
Sponsor:
Wiseman Research Initiatives, LLC
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00095862
First received: November 9, 2004
Last updated: October 26, 2011
Last verified: October 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has suspended participant recruitment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |